Pioglitazone Has Limited Effect in Lipoatrophic Diabetes
Slight liver function improvement seen in lipoatrophic diabetes induced by juvenile dermatomyositis
Insurer Market Power Lowers Providers’ Prices
Evidence seen for specialists in markets with high provider, insurer concentration
ACP Does Not Support Legalization of Assisted Suicide
Legalization would affect trust in the patient-physician relationship, and in the medical profession
Anagliptin Effect on LDL in T2DM Via ApoB-100 Synthesis
Improvement appears mediated, at least in part, through suppression of apoB-100 synthesis
AHA: Target Organ Damage From HTN Also Seen in Teenagers
Sixteen percent of teenagers had left ventricular hypertrophy with SBP below the 95th percentile
AHA: Multifaceted Intervention Improves BP Control
Increase in BP control from 65.6% to 74.8%, with significant increase in control in 12 of 16 practices
CGM Use in Pregnancy Improves Neonatal Outcomes
No apparent benefit for continuous glucose monitoring for women planning pregnancy
Greater Benefit for Pioglitazone in High-Risk Patients Post Stroke
Patients at higher risk for stroke or MI derive greater benefit from pioglitazone versus low-risk patients
Sleep Quality, Duration Linked to CKD Progression
Shorter sleep duration, greater sleep fragmentation linked to greater decline in eGFR
‘Science Spin’ Found Prevalent in Biomedical Literature
Nature of spin varies, with highest variability in prevalence of spin seen in trials
